Latest Ratings for PTEN Date Firm Action From To Feb 2022 Piper Sandler Maintains Overweight Feb 2022 Citigroup Maintains Buy Feb 2022 JP Morgan Maintains Underweight View More Analyst Ratings for PTEN View the Latest Analyst Ratings read more
Latest Ratings for CHD Date Firm Action From To Mar 2022 Atlantic Equities Downgrades Neutral Underweight Feb 2022 Argus Research Downgrades Buy Hold Jan 2022 Credit Suisse Downgrades Outperform Neutral View More Analyst Ratings for CHD View the Latest Analyst Ratings read more
Major cryptocurrencies are in the red as macro uncertainty and trade war tensions weigh on sentiment. read more
Palantir Technologies Inc (NASDAQ:PLTR) shares are rising on Tuesday despite a pullback in broader markets. The stock appears to be moving on continued momentum after the company announced that NATO acquired one of its AI-powered military systems. read more
Shares of Riot Platforms Inc. (NASDAQ: RIOT) are trading lower Monday, nearing 52-week lows as crypto-linked stocks continue to face selling pressure amid broad investor caution and recent company updates. read more
Certain ETFs are best suited for when markets are rebounding, while others, like Invesco QQQ Trust, are for those who prefer to play it safe. read more
Novavax updated Covid vaccine showed fewer and milder side effects than Pfizer-BioNTech’s in a Utah study. read more
American Airlines stock rises as it announces free inflight Wi-Fi for AAdvantage members through a new partnership with AT&T. read more
BofA downgrades Dow to Underperform, citing macro headwinds, tariff risks, and growing pressure on dividend sustainability. Latest Ratings for DOW Date Firm Action From To Jan 2022 Goldman Sachs Maintains Neutral Jan 2022 Goldman Sachs Maintains Neutral Jan 2022 Mizuho Maintains Neutral View More Analyst Ratings for DOW View the Latest Analyst Ratings read more
Merck signs deal with Austria’s Cyprumed to develop oral peptide therapies, potentially paying up to $493 million for access to delivery technology. read more